Learn more about whether Legend Biotech Corporation or Moderna, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Learn more about whether Alvotech or Moderna, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Morgan Stanley lowered the firm’s price target on Moderna (MRNA) to $32 from $39 and keeps an Equal Weight rating on the shares. The firm ...

In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on Moderna (MRNA – Research Report), with a price target ...

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine ...

Story Feb. 13 - Moderna: The big biotech is revamping its digital team, eliminating 10% of roles under two digital departments, affecting about 50 employees. The IT workforce reductions come as ...

As a biotechnology company, Moderna shares may have faced additional pressures amidst general concerns about economic growth and... Moderna (NasdaqGS:MRNA) recently experienced a 17% decline in ...

Moderna and BioNTech, two rising stars in biotech, were in the limelight this year with their pioneering mRNA vaccines against COVID-19. Just who are these companies and who is behind them ...

Biotech investors are reeling after the sudden departure of Peter Marks, a pivotal figure in the U.S. Food and Drug Administration. Marks, who played a crucial role in Operation Warp Speed and ...

They are made by Novavax, Moderna, and Pfizer, along with its partner BioNTech. Beyond the pending Novavax approval, the FDA must in the coming weeks advise Covid vaccine manufacturers on how to ...